• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VYGON GMBH EPICUTANEO CAVA CATHETER; LONG-TERM INTRAVASCULAR CATHETE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VYGON GMBH EPICUTANEO CAVA CATHETER; LONG-TERM INTRAVASCULAR CATHETE Back to Search Results
Model Number 2184.00
Device Problem Material Fragmentation (1261)
Patient Problems Device Embedded In Tissue or Plaque (3165); No Information (3190)
Event Date 05/05/2020
Event Type  Injury  
Manufacturer Narrative
The failed sample will be returned to vygon for device evaluation as part of the complaint investigation.The results of this investigation are still pending and will be communicated to fda within 30 days of its conclusion.
 
Event Description
Preterm newborn patient, required administration of total parenteral nutrition by picc catheter, on tolerating oral route total parenteral nutrition is suspended and withdrawal of the picc catheter located in the left upper limb is ordered, at the time of withdrawal incomplete catheter is observed and by measure 14.5 cm remain inside the patient, urgent catheterization is scheduled for removal of the device the procedure was performed without complications, stable patient.
 
Manufacturer Narrative
This complaint is not confirmed.We just received the distal catheter fragment with a length of 14,2 cm.Microscopic examination showed typical signs for a pressure burst.The tear of the burst runs around and could therefore lead to the catheter being separated.No signs of occlusions were visible.The product's ifu regarding stylet problems states the following in regards to avoiding pressure bursts: ""caution: do not use small syringes (<10ml) as these can generate very high pressures.It is possible to generate 4 or 5 times the maximum safety pressure, with any size of handheld syringe.Subjecting the catheter to pressure above 1.2 bar can result in catheter rupture and embolism; 1.Do not use infusion equipment which can exceed the working pressure of 1,0bar max/760 mm hg.2.Bolus injections should be slow and must not exceed the maximum bolus pressure of 1,2bar/900 mm hg.; 3.Do not use syringes smaller than 10 cc.Smaller syringes generate higher pressures than larger ones." a review of the batch history records showed no deviations.Each catheter is flow and leak tested during production.The tensile force of the catheter components is randomly checked.Incoming goods inspections and two 100% visual tests after packaging are carried out.This is the very first complaint for the possibly batches 250319gg and 170419gg and the fifth regarding a snapped catheter on code 2184.00 within the last three years.No further corrective action initiated by quality management as there are no indications for a manufacturing fault.
 
Event Description
Preterm newborn patient, required administration of total parenteral nutrition by picc catheter, on tolerating oral route total parenteral nutrition is suspended and withdrawal of the picc catheter located in the left upper limb is ordered, at the time of withdrawal incomplete catheter is observed and by measure 14.5cm remain inside the patient, urgent catheterization is scheduled for removal of the device the procedure was performed without complications, stable patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPICUTANEO CAVA CATHETER
Type of Device
LONG-TERM INTRAVASCULAR CATHETE
Manufacturer (Section D)
VYGON GMBH
prager ring 100
aachen 52070
GM  52070
MDR Report Key10158840
MDR Text Key195280524
Report Number2245270-2020-00038
Device Sequence Number1
Product Code LJS
Combination Product (y/n)N
PMA/PMN Number
K897168
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 08/12/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/16/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model Number2184.00
Device Lot Number250319GG
Was Device Available for Evaluation? Yes
Date Manufacturer Received06/12/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-